DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.99
-0.53 (-2.46%)
At close: Feb 27, 2026, 4:00 PM EST
20.58
-0.41 (-1.95%)
After-hours: Feb 27, 2026, 7:32 PM EST
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $1.25 billion as of February 27, 2026. Its market cap has increased by 1,475.51% in one year.
Market Cap
1.25B
Enterprise Value
1.19B
1-Year Change
1,475.51%
Ranking
Category
Stock Price
$20.99
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has increased from $844.80M to $1.25B, an increase of 48.26%. That is a compound annual growth rate of 3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 709.90M | 9.48% |
| Dec 31, 2025 | 648.40M | 987.92% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
| Oct 22, 2014 | 844.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immatics | 1.39B |
| Rapport Therapeutics | 1.38B |
| ORIC Pharmaceuticals | 1.35B |
| Precigen | 1.34B |
| AtaiBeckley | 1.32B |
| Septerna | 1.30B |
| MoonLake Immunotherapeutics | 1.26B |
| Taysha Gene Therapies | 1.24B |